UPMC Cancer Centers and the Leukemia and Lymphoma Society Present, ‘A Reason to Hope: Advances in the Treatment of Hodgkin’s Lymphoma’

PITTSBURGH, Oct. 4 – This year, doctors will diagnose about 7,800 new cases of Hodgkin’s lymphoma in the United States alone, as estimated by the American Cancer Society. This disease does, however, have many treatment options, and patients and their families can benefit from having the right information.

To provide the latest information about Hodgkin’s lymphoma treatment advances, UPMC Cancer Centers and the Leukemia and Lymphoma Society will co-sponsor, “A Reason to Hope: Advances in the Treatment of Hodgkin’s Lymphoma,” which will take place from 6:30 to 8 p.m., Thursday, Oct. 19, in the William Cooper Pavilion Classrooms, ground floor of the Hillman Cancer Center, 5115 Centre Ave., Shadyside. This event is part of a series of cancer lectures.

Presented by Anastasios Raptis, MD, PhD, from the division of hematology and oncology at the UPMC Cancer Centers and the University of Pittsburgh Cancer Institute, the talk welcomes patients, their families and the public.

The event is free and open to the public. Free parking is available in the UPMC Shadyside Medical Center Garage on Centre Avenue. Registration is required as seating is limited. Refreshments will be served. For further questions or to register, please call (412) 623-3651

# # #